Dr. Ravi Kumar Rajan

Dr. Ravi Kumar Rajan

Assistant professor


Dr. Ravi Kumar Rajan, M.Pharm., Ph.D., was born on 4thSeptember 1989 in the picturesque town of Ziro, Arunachal Pradesh. He hails from a loving family that includes his parents, two younger sisters, his devoted wife, and their adorable daughter.

Ravi’s academic journey began with his higher secondary education at Kendriya Vidhyalaya Naharlagun in 2005. He continued his pursuit of knowledge by earning a Bachelor’s degree in Pharmacy in 2012 from Swamy Vivekanandha College of Pharmacy, affiliated with The Tamil Nadu Dr. M.G.R. Medical University. His passion for pharmacology led him to complete a Master’s in Pharmacy in 2014 from PSG College of Pharmacy, specializing in Pharmacology, also affiliated with The Tamil Nadu Dr. M.G.R. Medical University.

His thirst for scientific exploration led him to a DST-funded project on breast cancer, where he worked as a full-time Junior Research Fellow. Subsequently, under the guidance of Educator and Scientist Prof. (Dr.) M. Ramanathan, embarked on a Ph.D. journey, focusing on “Pre-clinical evaluation of neuroprotective effects of terpenes/terpenoids and stilbenoids in ischemia disease”, and was awarded in July 2022. His outstanding research was recognized with the second prize at the 7th Ph.D. Poster Symposium by the “Royal Society of Chemistry”, held at NIPER Hyderabad.

Ravi’s philosophy in life is to “Always be enthusiastic and eager to learn, because discoveries are made by those who are enthusiastic and eager to search and learn.”

During his academic journey, Ravi honed his skills in mammalian cell culture, molecular biology techniques, and drug discovery tools provided by Schrödinger.

In August 2020, Ravi joined the School of Pharmacy at Arunachal University of Studies as an Assistant Professor, making a significant impact on the budding pharmacists of the region. In April 2022, he moved to the School of Pharmaceutical Sciences, Girijananda Chowdhury Institute of Pharmacy, Tezpur Campus, where he continues to inspire and educate the next generation of pharmaceutical experts.

Beyond academia and adventure, Ravi’s interests include sports like football, cricket, and badminton, and he’s an avid reader of scientific articles and a fan of sci-fi movies, particularly those from the Marvel and DC universes.

In addition to his academic pursuits and love for adventure, Ravi is an avid traveler who enjoys exploring unknown places for tracking and adventure, seeking excitement and discovery beyond the laboratory.

As for his future, Ravi aspires to make significant contributions in the field of neuropharmacology for the betterment of society, furthering his commitment to scientific discovery and societal welfare.


  • Bachelor of Pharmacy 2012The Tamil Nadu Dr. MGR Medical University, Guindy, Chennai, Tamil Nadu
  • Master of Pharmacy 2014 The Tamil Nadu Dr. MGR Medical University, Guindy, Chennai, Tamil Nadu
  • Ph.D 2022The Tamil Nadu Dr. MGR Medical University, Guindy, Chennai, Tamil Nadu


  • Soy isoflavones exert beneficial effects on letrozole-induced rat polycystic ovary syndrome (PCOS) model through anti-androgenic mechanism
  • Identification and neuroprotective evaluation of a potential c-Jun N-terminal kinase 3 inhibitor through structure-based virtual screening and in-vitro assay
  • Crystal structure, Hirshfeld surface analysis, DFT, and molecular docking studies on benzohydrazide derivatives as potential inhibitors of prostate cancer
  • Synthesis and Characterization of Folic Acid Conjugated Gemcitabine Tethered Silver Nanoparticles (FA-GEM-AgNPs) for Targeted Delivery
  • Cytotoxicity and Synergistic Effect of Biogenically Synthesized Ternary Therapeutic Nano Conjugates Comprising Plant Active Principle, Silver and Anticancer Drug on MDA-MB-453 Breast Cancer Cell Line
  • In-silico and in-vitro analysis of novel substituted benzimidazolyl derivatives for antimycobacterial potentials targeting enoyl acyl carrier protein reductase (InhA
  • Design, Synthesis, and Biological Evaluation of 2-(2-Bromo-3-nitrophenyl)-5-phenyl-1,3,4-oxadiazole Derivatives as Possible Anti-Breast Cancer Agents
  • Building and behavior of a pH-stimuli responsive chitosan nanoparticles loaded with folic acid conjugated gemcitabine silver colloids in MDA-MB-453 metastatic breast cancer cell line and pharmacokinetics in rats

Award, Fellowship & Recognition

  • Biogenic Synthesis of silver Nanoconjugates with Natural Products for breast cancer (D.O.No.SR/NM/NS-1110/2013 dated 05.06.2014)